Watch the full interview now, where Karla also shares her thoughts on key trends disrupting the biotech industry today, as well as her forecasts for the most critical success factors for biotech firms over the next five years!
In this conversation with Fierce Biotech, we explore the ever-evolving biotech landscape. Chiefly, Sailer highlights the transformative impact of AI and machine learning in drug development, a trend which, he believes, can potentially double approval rates while reducing costs and time-to-market.
Fierce Biotech sat down with Pavel Raifeld, CEO of Innoviva, to explore the dynamic landscape of the biotech industry. Throughout the conversation, Raifeld offers a unique perspective on the most significant trends shaping the sector today, with a particular focus on the critical role of capital access.
